Phase I/II Study of Stereotactic Radiosurgery with Concurrent Olaparib Followed by Adjuvant Durvalumab and Physician's Choice Systemic Therapy in Patients with Breast Cancer Brain Metastases
NEURO-ONCOLOGY(2024)
Key words
HER2-Positive Breast Cancer,PARP Inhibitors,Brain Metastases,Cancer Therapy,BRCA1/2 Deficiency
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined